<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31437" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Xanthochromia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dugas</surname>
            <given-names>Carla</given-names>
          </name>
          <aff>Inspira Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jamal</surname>
            <given-names>Zohaib</given-names>
          </name>
          <aff>Rawalpindi Medical University, Rawalpindi</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bollu</surname>
            <given-names>Pradeep C.</given-names>
          </name>
          <aff>University of Missouri</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Carla Dugas declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zohaib Jamal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pradeep Bollu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31437.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Xanthochromia is the observation of a yellowish discoloration in cerebrospinal fluid (CSF) attributed to the presence of bilirubin. This yellow hue, linked with various pigmented compounds from red blood cell breakdown, signifies conditions ranging from&#x000a0;jaundice and high CSF protein to aneurysmal and nonaneurysmal subarachnoid hemorrhage. Considering that many of the etiologies are life-threatening, an expedited evaluation and diagnosis are paramount when this condition is present.</p>
        <p>Expanding on the historical origins and contemporary definition of xanthochromia, this activity details diagnostic methods, spanning traditional visual assessment to more sensitive spectrophotometry. It further elucidates the comprehensive evaluation and management of xanthochromia, stressing the pivotal role of the interprofessional healthcare team in addressing this condition. Clinicians will gain insight into expedited diagnostic protocols, optimal management strategies, and collaborative approaches for enhanced patient care and outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the key etiologies associated with xanthochromia, including subarachnoid hemorrhage, jaundice-related conditions, and other catastrophic neurological causes, through clinical presentations and diagnostic tests.</p></list-item><list-item><p>Implement standardized diagnostic procedures for confirming xanthochromia, including cerebrospinal fluid analysis techniques and imaging modalities, to ensure accurate identification and differentiation of causes.</p></list-item><list-item><p>Identify potential complications associated with xanthochromia, such as neurological deficits, vasospasm, or rebleeding, through comprehensive clinical assessments and imaging studies.</p></list-item><list-item><p>Implement a cohesive care plan integrating expertise from diverse specialties, emphasizing timely diagnostic evaluations and multidisciplinary treatment strategies to improve outcomes for patients with xanthochromia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31437&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31437">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31437.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Xanthochromia&#x000a0;is derived from the Greek word "xanthos,"&#x000a0;meaning yellow.&#x000a0;The term was first used to describe the pink or yellow pigmentation of cerebrospinal fluid (CSF).<xref ref-type="bibr" rid="article-31437.r1">[1]</xref> This color change is attributed to varying concentrations of pigmented compounds such as oxyhemoglobin, bilirubin, and methemoglobin, which&#x000a0;are typically&#x000a0;the byproducts of red blood cell degradation.<xref ref-type="bibr" rid="article-31437.r2">[2]</xref> The term is now more widely accepted to represent the yellow color created by the presence of bilirubin in the CSF. The presence of bilirubin resulting in yellow discoloration of the CSF is the contemporary definition of xanthochromia.<xref ref-type="bibr" rid="article-31437.r3">[3]</xref><xref ref-type="bibr" rid="article-31437.r4">[4]</xref><xref ref-type="bibr" rid="article-31437.r5">[5]</xref>&#x000a0;It can be diagnosed by&#x000a0;2 methods: the traditional visualization or eye test and the more sensitive and specific spectrophotometry.&#x000a0;</p>
      </sec>
      <sec id="article-31437.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The yellowish hue seen with xanthochromia is caused by the presence of bilirubin, which is the byproduct of the degradation of oxyhemoglobin by the enzyme oxygenase. In the CSF, this occurs by the macrophages that line the arachnoid space. There are many causes of xanthochromia, including acute intracerebral hemorrhage, brain tumors, infection, conditions that cause an increase of CSF protein (&#x02265;150 mg/dL), and severe systemic jaundice (serum bilirubin levels &#x0003e;10 g/dL). The finding of xanthochromia in the CSF is most commonly used in diagnosing subarachnoid hemorrhage (SAH) in the presence of a normal head computed tomography (CT).<xref ref-type="bibr" rid="article-31437.r6">[6]</xref><xref ref-type="bibr" rid="article-31437.r7">[7]</xref></p>
      </sec>
      <sec id="article-31437.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The true prevalence and incidence of xanthochromia are not known, as various pathologies can cause it; however, it is more commonly discussed surrounding the diagnosis of a ruptured intracerebral aneurysm, which most commonly causes SAH. The incidence of SAH is anywhere from 9 to 15 people per 100,000 in the United States (US), with rates that vary by geography. Risk factors for SAH include hypertension, cigarette smoking, alcohol use, some sympathomimetic drugs, and some genetic causes that increase the risk of a cerebral aneurysm.<xref ref-type="bibr" rid="article-31437.r8">[8]</xref>&#x000a0;</p>
        <p>It is known that xanthochromia can be seen very soon&#x000a0;after an SAH&#x000a0;(up to 2 hours);&#x000a0;within 12 hours of a ruptured SAH, more than 90% of patients will show xanthochromia in their CSF that can persist for up to&#x000a0;4 weeks.<xref ref-type="bibr" rid="article-31437.r9">[9]</xref>&#x000a0;With newer imaging options and better-quality CT scanners&#x000a0;available, the diagnosis of SAH is most commonly made with either a noncontrasted CT of the brain or a CT-angiogram (CTA) of the brain. However, SAH can be missed on imaging, and analysis of CSF for xanthochromia can help with the diagnosis of SAH&#x000a0;(which occurs in &#x0003c;1% of cases), as it has a 100% sensitivity and 99% specificity when using the United Kingdom National External Quality Assessment Service (UK-NEQAS)&#x000a0;method of spectrophotometry is used.<xref ref-type="bibr" rid="article-31437.r6">[6]</xref><xref ref-type="bibr" rid="article-31437.r10">[10]</xref></p>
      </sec>
      <sec id="article-31437.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>No matter the etiology, xanthochromia represents the presence of degraded red blood cells. This process takes place over time as blood is degraded by macrophages and broken down into its byproducts containing bilirubin.&#x000a0;Conversion from heme to bilirubin in the CSF takes roughly 6 to 12 hours.&#x000a0;Therefore, xanthochromia is best identified 6 to 12 hours after the onset of a bleed, and its&#x000a0;presence suggests that blood has been present in the spinal fluid for at least&#x000a0;2 hours, with 100% of patients having xanthochromia present by visual inspection by 12 hours.<xref ref-type="bibr" rid="article-31437.r11">[11]</xref>&#x000a0;</p>
        <p>Xanthochromia is seen in over 90% of patients very&#x000a0;soon after an SAH and can be present for up to&#x000a0;3 to 4 weeks, with some studies showing that&#x000a0;more than 75% of patients can have xanthochromia present at 21 days following SAH. Even though a noncontrasted CT scan of the brain is the initial imaging modality of choice for a suspected SAH, nearly 5% of cases will have no CT evidence of hemorrhage within the first 24 hours.<xref ref-type="bibr" rid="article-31437.r12">[12]</xref> This percentage increases to 50% by the first week and is about 30% at&#x000a0;2 weeks.&#x000a0;</p>
      </sec>
      <sec id="article-31437.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>There are currently&#x000a0;2 different methods to identify xanthochromia in the CSF.</p>
        <p>
<bold>Visual Detection </bold>
</p>
        <p>In the US, visual detection is still one of the most commonly&#x000a0;used methods to evaluate patients for xanthochromia. During this process, a CSF sample is spun in a centrifuge, and the supernatant is visually inspected with the naked eye for a yellow or pink tint.&#x000a0;This is accomplished by holding a vial of water next to a vial of supernatant against a white backdrop.&#x000a0;A yellow or pink tint&#x000a0;suggests that blood has been in the spinal fluid for at least&#x000a0;2 hours, with 100% of patients having xanthochromia present by visual inspection by 12 hours.<xref ref-type="bibr" rid="article-31437.r11">[11]</xref>&#x000a0;</p>
        <p>False positives can&#x000a0;result from several causes, including patients&#x000a0;taking rifampin, those eating excess carotenoids (carrots and spinach), the presence of clinical jaundice, and elevated protein levels in the CSF (&#x0003e;150 mg/dL). Some common causes of elevated CSF protein include carcinomatosis, intracranial neoplasms, Froin's syndrome, tuberculosis,&#x000a0; cryptococcal meningitis, and radicular demyelination.&#x000a0;</p>
        <p>
<bold>Spectrophotometry</bold>
</p>
        <p>The second and perhaps more reliable way to test for xanthochromia is by using spectrophotometry.<xref ref-type="bibr" rid="article-31437.r13">[13]</xref> A spectrophotometer measures the absorption of light in&#x000a0;a material and identifies that material based on the wavelength of light it absorbs. Bilirubin itself has a narrow window of detection with a wavelength of 440 to 460 nm.</p>
        <p>Multiple studies show&#x000a0;the superiority of spectrophotometry when compared&#x000a0;with visual inspection.<xref ref-type="bibr" rid="article-31437.r14">[14]</xref> There are several factors that can interfere with the appearance of xanthochromia on visual inspection alone. For instance, the presence of proteins or pigments such as carotenoids can obscure the color change associated with the presence of xanthochromia. The presence of oxyhemoglobin with an acute bleed or traumatic lumbar puncture appears pink or orange and can hide the yellow discoloration of xanthochromia, leading to a false-negative result. Furthermore, unlike spectrophotometry, a visual inspection cannot detect low concentrations of bilirubin and cannot distinguish bilirubin from oxyhemoglobin.<xref ref-type="bibr" rid="article-31437.r3">[3]</xref></p>
      </sec>
      <sec id="article-31437.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients who have xanthochromia can have a variety of conditions, with the most&#x000a0;severe being an SAH. Although rare, SAH carries significant morbidity and mortality risk, as it can lead to sudden death and disability if not diagnosed and treated properly. Patients often present complaining of the worst headache of their life.<xref ref-type="bibr" rid="article-31437.r5">[5]</xref>&#x000a0;A&#x000a0;sudden onset at a maximal intensity or within the first hour of onset&#x000a0;often characterizes headaches. They can be associated with meningismus, nausea, vomiting, photophobia, or phonophobia but rarely with acute neurologic deficits.<xref ref-type="bibr" rid="article-31437.r15">[15]</xref>&#x000a0;It can be difficult to distinguish between a nontraumatic headache associated with SAH or another lessseveres cause.</p>
      </sec>
      <sec id="article-31437.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Noncontrast&#x000a0;CT of the head&#x000a0;(NCHCT) is still the initial test of choice in the diagnosis of SAH.<xref ref-type="bibr" rid="article-31437.r16">[16]</xref> The sensitivity of this test is greatest within the first 6 hours of the onset of symptoms.<xref ref-type="bibr" rid="article-31437.r5">[5]</xref> The current standard of care is to obtain an NCHCT followed by a lumbar puncture to evaluate for xanthochromia if the NCHCT is negative. The finding of xanthochromia in the CSF is helpful in that it is 93% sensitive and 95% specific, with a positive predictive value of 72% and a negative predictive value of 99%.<xref ref-type="bibr" rid="article-31437.r17">[17]</xref>&#x000a0;</p>
        <p>Xanthochromia is typically present in the CSF within 6 to 12 hours after the onset of symptoms. Unlike CT, xanthochromia is present in the CSF in all patients up to 2 weeks post ictus and is still present in 70% of patients up to&#x000a0;3 weeks later.<xref ref-type="bibr" rid="article-31437.r11">[11]</xref>&#x000a0;Furthermore, sensitivity for detecting a bleed by CT decreases from up to 95% on day 1 to less than 10% in 3 weeks, with the sensitivity of CSF analysis remaining constant near 100% over this time.<xref ref-type="bibr" rid="article-31437.r14">[14]</xref>&#x000a0;Because the production of bilirubin is a process that happens only in vivo, the presence of xanthochromia in the CSF is the only way to differentiate between a true hemorrhage and a traumatic tap, as both can contain large amounts of red blood cells.<xref ref-type="bibr" rid="article-31437.r18">[18]</xref></p>
      </sec>
      <sec id="article-31437.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Once the patient is diagnosed with an SAH based on the findings of xanthochromia in the CSF, they may be sent for magnetic resonance imaging (MRI) or CTA&#x000a0;or taken directly for treatment. The next step in management is to find the location of an aneurysm and, thus, the cause of the SAH.<xref ref-type="bibr" rid="article-31437.r19">[19]</xref></p>
      </sec>
      <sec id="article-31437.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for&#x000a0;xanthochromia include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aneurysmal leaks</p>
          </list-item>
          <list-item>
            <p>Severe hyperbilirubinemia</p>
          </list-item>
          <list-item>
            <p>SAH</p>
          </list-item>
          <list-item>
            <p>Sentinel hemorrhage</p>
          </list-item>
          <list-item>
            <p>Excess carotenoid intake (carrots and spinach)</p>
          </list-item>
          <list-item>
            <p>Conditions that cause elevated protein levels in the CSF&#x000a0;(eg, carcinomatosis, intracranial neoplasms, Froin's syndrome, tuberculosis, cryptococcal meningitis, and radicular demyelination)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31437.s11" sec-type="Complications">
        <title>Complications</title>
        <p>It is challenging to determine the pretest probability of SAH based on a single presentation alone, as no one factor could determine the need for further testing for an acute nontraumatic headache. Lumbar puncture is an invasive procedure, and often the results are misleading and nondiagnostic.<xref ref-type="bibr" rid="article-31437.r20">[20]</xref><xref ref-type="bibr" rid="article-31437.r21">[21]</xref>&#x000a0;However, there is a particular subset of patients in whom a lumbar puncture can identify xanthochromia and help correctly diagnose those with SAH.</p>
        <p>Most patients with negative head CT will not be diagnosed with SAH. However, the overuse of CTA can expose patients to unnecessary radiation.<xref ref-type="bibr" rid="article-31437.r22">[22]</xref>&#x000a0;Furthermore, the use of CTA leads to the finding of incidental aneurysms, which may or may not be clinically significant.&#x000a0;This, in turn, may expose the patient to even more unnecessary testing and intervention. In these cases, A&#x000a0;lumbar puncture has a high diagnostic yield, potentially eliminating the need for neurosurgical consultation or intervention in most cases with a low risk of&#x000a0;infection, bleeding, and postdural headache.<xref ref-type="bibr" rid="article-31437.r23">[23]</xref>&#x000a0;The test is cost-effective, time-efficient, and can potentially reduce the number of patients exposed to the radiation and contrast associated with angiography.<xref ref-type="bibr" rid="article-31437.r23">[23]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31437.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Xanthochromia&#x000a0;describes the presence of yellowish supernatant in the CSF that is caused by the presence of bilirubin.</p>
          </list-item>
          <list-item>
            <p>The presence of xanthochromia on visual inspection can also be seen in other conditions; increased vitamin A intake, certain medications like rifampin,&#x000a0;and other infectious conditions can lead to false positives.</p>
          </list-item>
          <list-item>
            <p>Visual inspection of the CSF is the most common method of detection in the US</p>
          </list-item>
          <list-item>
            <p>Spectrophotometry&#x000a0;is proven to be a superior method of detection to that of visual inspection.<xref ref-type="bibr" rid="article-31437.r3">[3]</xref><xref ref-type="bibr" rid="article-31437.r14">[14]</xref><xref ref-type="bibr" rid="article-31437.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>It is essential&#x000a0;to know the screening pitfalls of those with possible&#x000a0;SAH, as there are false positive and false negative scenarios.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31437.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Observing xanthochromia in CSF is an important diagnostic finding, given the potential morbidity of&#x000a0;an underlying illness such as SAH. Because of&#x000a0;the limitations of CT imaging for detecting SAH, the presence of xanthochromia might be the&#x000a0;only evidence pointing to its diagnosis.</p>
        <p>Twenty-four&#x000a0;hours&#x000a0;after symptom onset, CT scans give an increasing false negative rate for SAH. Therefore, there must be&#x000a0;good communication between the ordering physician and the radiologist regarding the clinical history and appropriate imaging modality.</p>
        <p>Standard practice in diagnosing SAH&#x000a0;with a negative head CT still includes using a lumbar puncture to detect the presence of xanthochromia. This test is more cost-effective and may reduce the need for CTA with contrast in many patients.<xref ref-type="bibr" rid="article-31437.r23">[23]</xref><xref ref-type="bibr" rid="article-31437.r25">[25]</xref><xref ref-type="bibr" rid="article-31437.r26">[26]</xref>&#x000a0;</p>
        <p>Additionally, collaboration with&#x000a0;the hospital's lab technicians is important, as understanding which method they use for evaluating xanthochromia can help with differential diagnoses. Traditionally, xanthochromia is detected in the lab by visualizing the supernatant CSF under incandescent light for the presence of a yellow tint. Multiple studies have shown the superiority of using spectrophotometry instead of visualization; despite this finding, visual inspection remains the most commonly used modality in the US. Spectrophotometry can detect the presence of xanthochromia at smaller concentrations than the naked eye. It is more specific, as it relies on detecting a certain wavelength of emitted light corresponding to xanthochromia.<xref ref-type="bibr" rid="article-31437.r24">[24]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31437.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31437&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31437">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/xanthochromia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31437">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31437/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31437">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-31437.s15">
        <fig id="article-31437.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Lumbar puncture Image courtesy O.Chaigasame</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="xanthochromia" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-31437.s16">
        <title>References</title>
        <ref id="article-31437.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Edlow</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Distinguishing traumatic lumbar puncture from true subarachnoid hemorrhage.</article-title>
            <source>J Emerg Med</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-74</page-range>
            <pub-id pub-id-type="pmid">12217474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seehusen</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Fomin</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Cerebrospinal fluid analysis.</article-title>
            <source>Am Fam Physician</source>
            <year>2003</year>
            <month>Sep</month>
            <day>15</day>
            <volume>68</volume>
            <issue>6</issue>
            <fpage>1103</fpage>
            <page-range>1103-8</page-range>
            <pub-id pub-id-type="pmid">14524396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Spectrophotometry, not visual inspection for the detection of xanthochromia in suspected subarachnoid haemorrhage: A debate.</article-title>
            <source>Emerg Med Australas</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-72</page-range>
            <pub-id pub-id-type="pmid">25919441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gill</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Marcolini</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Barber</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wira</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>The Utility of Lumbar Puncture After a Negative Head CT in the Emergency Department Evaluation of Subarachnoid Hemorrhage.</article-title>
            <source>Yale J Biol Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>91</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-11</page-range>
            <pub-id pub-id-type="pmid">29599652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Koyfman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Runyon</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Subarachnoid Hemorrhage: Updates in Diagnosis and Management.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>803</fpage>
            <page-range>803-824</page-range>
            <pub-id pub-id-type="pmid">28987430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rankin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McGuire</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chekroud</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alakandy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Evaluating xanthochromia in the diagnosis of subarachnoid haemorrhage in Scotland in the Era of modern computed tomography.</article-title>
            <source>Scott Med J</source>
            <year>2022</year>
            <month>May</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-77</page-range>
            <pub-id pub-id-type="pmid">35105220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ichiba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nishikawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanabe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Urashima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Naitou</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Comprehensive Evaluation of Diagnostic and Treatment Strategies for Idiopathic Spinal Subarachnoid Hemorrhage.</article-title>
            <source>J Stroke Cerebrovasc Dis</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>12</issue>
            <fpage>2840</fpage>
            <page-range>2840-2848</page-range>
            <pub-id pub-id-type="pmid">28802522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with traumatic fluoroscopy-guided lumbar punctures: a retrospective review.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>512</fpage>
            <page-range>512-5</page-range>
            <pub-id pub-id-type="pmid">19147709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <collab>UK National External Quality Assessment Scheme for Immunochemistry Working Group</collab>
            <article-title>National guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>Pt 5</issue>
            <fpage>481</fpage>
            <page-range>481-8</page-range>
            <pub-id pub-id-type="pmid">14503985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazer</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Koroneos</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Orwitz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Corn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wirkowski</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The Diagnostic Dilemma in Delayed Subarachnoid Hemorrhage: A Case Report.</article-title>
            <source>Clin Pract Cases Emerg Med</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-177</page-range>
            <pub-id pub-id-type="pmid">37595310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vermeulen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hasan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Blijenberg</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Hijdra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Gijn</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Xanthochromia after subarachnoid haemorrhage needs no revisitation.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1989</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>7</issue>
            <fpage>826</fpage>
            <page-range>826-8</page-range>
            <pub-id pub-id-type="pmid">2769274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chakraborty</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Daneshmand</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lanzino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hocker</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>CT-Negative Subarachnoid Hemorrhage in the First Six Hours.</article-title>
            <source>J Stroke Cerebrovasc Dis</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>12</issue>
            <fpage>105300</fpage>
            <pub-id pub-id-type="pmid">33051138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petzold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Keir</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sharpe</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>Spectrophotometry for xanthochromia.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Oct</month>
            <day>14</day>
            <volume>351</volume>
            <issue>16</issue>
            <fpage>1695</fpage>
            <page-range>1695-6</page-range>
            <pub-id pub-id-type="pmid">15483297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petzold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Keir</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sharpe</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Why human color vision cannot reliably detect cerebrospinal fluid xanthochromia.</article-title>
            <source>Stroke</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>1295</fpage>
            <page-range>1295-7</page-range>
            <pub-id pub-id-type="pmid">15879320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Rabinstein</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>David Freeman</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Recognizing the signs and symptoms of aneurysmal subarachnoid hemorrhage.</article-title>
            <source>Expert Rev Neurother</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>7</issue>
            <fpage>757</fpage>
            <page-range>757-68</page-range>
            <pub-id pub-id-type="pmid">24949896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abraham</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>WW</given-names>
              </name>
            </person-group>
            <article-title>Subarachnoid Hemorrhage.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>901</fpage>
            <page-range>901-916</page-range>
            <pub-id pub-id-type="pmid">27741994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dupont</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Wijdicks</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Manno</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Rabinstein</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Thunderclap headache and normal computed tomographic results: value of cerebrospinal fluid analysis.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>83</volume>
            <issue>12</issue>
            <fpage>1326</fpage>
            <page-range>1326-31</page-range>
            <pub-id pub-id-type="pmid">19046551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mark</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Kene</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Offerman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Vinson</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Ballard</surname>
                <given-names>DW</given-names>
              </name>
              <collab>Kaiser Permanente CREST Network</collab>
            </person-group>
            <article-title>Validation of cerebrospinal fluid findings in aneurysmal subarachnoid hemorrhage.</article-title>
            <source>Am J Emerg Med</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>9</issue>
            <fpage>1249</fpage>
            <page-range>1249-52</page-range>
            <pub-id pub-id-type="pmid">26022754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Oliveira Manoel</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Goffi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marotta</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Schweizer</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Abrahamson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The critical care management of poor-grade subarachnoid haemorrhage.</article-title>
            <source>Crit Care</source>
            <year>2016</year>
            <month>Jan</month>
            <day>23</day>
            <volume>20</volume>
            <fpage>21</fpage>
            <pub-id pub-id-type="pmid">26801901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doherty</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Forbes</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Lumbar Puncture.</article-title>
            <source>Ulster Med J</source>
            <year>2014</year>
            <month>May</month>
            <volume>83</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-102</page-range>
            <pub-id pub-id-type="pmid">25075138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wisborg</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Overuse of CT at the trauma centre?].</article-title>
            <source>Tidsskr Nor Laegeforen</source>
            <year>2019</year>
            <month>Mar</month>
            <day>12</day>
            <volume>139</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">30872827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohana</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Soffer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zimlichman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Klang</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Overuse of CT and MRI in paediatric emergency departments.</article-title>
            <source>Br J Radiol</source>
            <year>2018</year>
            <month>May</month>
            <volume>91</volume>
            <issue>1085</issue>
            <fpage>20170434</fpage>
            <pub-id pub-id-type="pmid">29271231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Teo</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Godber</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Mandalia</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>St George</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>McGregor</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Defending a traditional practice in the modern era: The use of lumbar puncture in the investigation of subarachnoid haemorrhage.</article-title>
            <source>Br J Neurosurg</source>
            <year>2015</year>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>799</fpage>
            <page-range>799-803</page-range>
            <pub-id pub-id-type="pmid">26373397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Greenslade</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Spectrophotometry or visual inspection to most reliably detect xanthochromia in subarachnoid hemorrhage: systematic review.</article-title>
            <source>Ann Emerg Med</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>256</fpage>
            <page-range>256-264.e5</page-range>
            <pub-id pub-id-type="pmid">24635988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goyale</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Shea</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marsden</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Keep</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Analysis of cerebrospinal fluid for xanthochromia versus modern computed tomography scanners in the diagnosis of subarachnoid haemorrhage: experience at a tertiary trauma referral centre.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>Pt 1</issue>
            <fpage>150</fpage>
            <page-range>150-4</page-range>
            <pub-id pub-id-type="pmid">25766384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31437.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Skagervik</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tumani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Petzold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>K&#x000fc;hn</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Uhr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Regeniter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brettschneider</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deisenhammer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lautner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Blennow</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zetterberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mattsson</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>51</volume>
            <issue>11</issue>
            <fpage>2073</fpage>
            <page-range>2073-86</page-range>
            <pub-id pub-id-type="pmid">23729569</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
